GlassScriptPhysician profile
Amit Todani
NPI 1295969848
$8,303.72
in general payments reported to CMS, 2019-2025
24 companies · $2,080 in 2025
The $2,080 reported for 2025 was more than what 89% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $581 · 2020: $224 · 2021: $1,175 · 2022: $1,065 · 2023: $1,487 · 2024: $1,692 · 2025: $2,080.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,156 · Entertainment: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,156.45 |
| Entertainment | $103.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,956.31 | 2019-2025 | Rocklatan, Argos, Tryptyr |
| Glaukos Corporation | $1,207.30 | 2019-2025 | Idosetr, Photrexa Viscous and Photrexa, Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Sun Pharmaceutical Industries INC. | $850.70 | 2019-2025 | Cequa |
| Abbvie INC. | $757.87 | 2022-2025 | Durysta, Lumigan, Alphagan P |
| Allergan, INC. | $514.31 | 2020-2022 | |
| Bausch & Lomb Americas INC. | $501.10 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Tarsus Pharmaceuticals, INC. | $381.64 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $270.16 | 2019-2025 | |
| Oyster Point Pharma, INC. | $255.92 | 2022-2025 | Tyrvaya, Ryzumvi |
| Rxsight INC | $226.29 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Dompe US, INC. | $204.25 | 2021-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $196.58 | 2022-2023 | |
| New World Medical,INC. | $195.84 | 2023-2024 | Streamline, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Ivantis, INC | $168.36 | 2021 | |
| Harrow Eye, LLC | $143.05 | 2024 | Iheezo |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lensar, INC. | $104.36 | 2019-2024 | Lensar Laser System |
| Optos, INC. | $103.31 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Thea Pharma INC. | $66.68 | 2023-2025 | Iyuzeh |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $47.90 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $41.08 | 2019-2020 | |
| Johnson & Johnson Surgical Vision, INC. | $35.36 | 2022 | |
| Maculogix, INC. | $30.97 | 2021 | |
| Genentech USA, INC. | $25.42 | 2022 | |
| Omeros Corporation | $18.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Todani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.